Public Health

The CDC confirmed another human bird flu case, marking the first instance of the virus in a human without occupational exposure to infected birds or dairy cattle during the 2024 outbreak.

As Medicare open enrollment begins, the NCPA is urging CMS to facilitate appropriate PBM contracting for pharmacies in the upcoming plan year.

Emergent BioSolutions has announced that it will donate 50,000 doses of ACAM2000 for potential deployment across affected areas in Central Africa.

Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.

The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.”

Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.

Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.

Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.

Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.

Participants were asked to rate their level of concern on 26 health topics.

First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.

A CDC report called for “increased efforts” to ensure parents can obtain all recommended vaccines for their eligible children and realize the full potential of the VFC program.

New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.

TAK-003 could be a powerful combatant against the increasing global threat of dengue virus.

A study found that test products purchased from illegal online pharmacy operations had lower purity levels and significantly more semaglutide content than what was advertised on the label.

Researchers aimed to address the change in trust individuals exhibited regarding US physicians and hospitals during the COVID-19 pandemic.

Industry experts explored the increase in US prescription drug spending and how state spending targets come into play regarding patients’ rising out-of-pocket costs.

Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.

“If people think COVID is no big deal and decide to forgo vaccinations, they’re essentially doubling their risk of developing long COVID,” wrote investigators.

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

The CDC issued a report on the state of the avian influenza, or bird flu, at the end of last week.

As the end of the DSCSA stabilization period approaches, Scott Mooney, vice president of distribution operations at McKesson, discussed what pharmacists should consider to be prepared.

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

The theme of this year’s National HIV Testing Day encourages individuals to self-test for HIV as a means of demonstrating their compassion for themselves.

Cases of Dengue virus—the most common global arboviral disease—are on the rise.

In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.

Patrick Alonso, PharmD, CPh, owner and manager of Your Tampa Health Care Advocates, talks about how to build trust with male patients, what health screenings men should be getting, and how pharmacists can help support men’s mental health.

The CDC released an alert encouraging pharmacists and providers to counsel patients around the harms of illegal stimulant medications.

The Supreme Court ruled on the question of limiting access to to mifepristone, a key abortion drug that anti-abortion groups have been working to limit across the country.

In a world rich with diversity, pharmacists need to understand how varied backgrounds and special needs can impact a patient’s decisions in managing their health and medication protocols.